Bayer launches LifeHub UK focused on AI for drug discovery

World |  News | 0 Comment | 11 Oct, 2019

Bayer has launched LifeHub UK to accelerate and optimize disease detection and data-driven drug discovery by developing artificial-intelligence-enabled imaging solutions. The new hub is the...Read more

Novo Nordisk, bluebird bio plan next-gen in vivo genome editing

World |  News | 0 Comment | 11 Oct, 2019

US headquartered bluebird bio, Inc. and Denmark based Novo Nordisk have announced that they have entered into a three-year research collaboration to jointly develop next-generation in vivo ...Read more

Noble Prize in Medicine 2019 for US, UK scientists

World |  News | 0 Comment | 07 Oct, 2019

The Nobel Prize in Physiology or Medicine for 2019 has been jointly awarded to three winners, William G. Kaelin Jr., Peter J. Ratcliffe and Gregg L. Semenza, for their work in discovering h...Read more

Study: High lead levels during pregnancy linked to child obesity

World |  Analysis | 0 Comment | 04 Oct, 2019

Children born to women who have high blood levels of lead are more likely be overweight or obese, compared to those whose mothers have low levels of lead in their blood, according to a stud...Read more

Scientists in UK identify cause of antibiotic resistance

World |  News | 0 Comment | 04 Oct, 2019

Scientists have confirmed for the first time that bacteria can change form to avoid being detected by antibiotics in the human body. Studying samples from elderly patients with recurring u...Read more

Novartis and Microsoft to transform medicine with AI

World |  News | 0 Comment | 03 Oct, 2019

Novartis has announced an important step in reimagining medicine by founding the Novartis AI innovation lab and by selecting Microsoft as its strategic AI and data-science partner for this ...Read more

AstraZeneca divests rights for Losec to Cheplapharm

World |  News | 0 Comment | 03 Oct, 2019

AstraZeneca, a global, science-led biopharmaceutical company has agreed to sell the global commercial rights, excluding China, Japan, the US and Mexico, for Losec (omeprazole) and...Read more

WHO launches app to improve elderly care

World |  News | 0 Comment | 02 Oct, 2019

On the International Day of Older Persons – 1 October – the World Health Organization (WHO) has launched  a package of tools, including a digital application to h...Read more

PharmaVentures establishes an International Advisory Board

World |  News | 0 Comment | 30 Sep, 2019

UK based PharmaVentures is pleased to announce the establishment of a new International Advisory Board, comprised of pharmaceutical, medical, transactional and investment banking experts fr...Read more

Kaspersky updates decryption tool to fight ransomware pair

World |  News | 0 Comment | 30 Sep, 2019

Ransomware is a dangerous threat to healthcare consumers and businesses, with new types of malware being developed rapidly by cybercriminals every day, in order to victimize users. Once loc...Read more

High drug costs despite public R&D funding in the millions

World |  Analysis | 0 Comment | 30 Sep, 2019

Ludwig Boltzmann Institute for Health Technology Assessment (Vienna, Austria) identifies public funding for the development of high-priced drugs. EUR 165 million in public and private R&...Read more

NIH awards contracts to advance tuberculosis immunology research

World |  News | 0 Comment | 27 Sep, 2019

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has awarded $30 million in first-year funding to establish new centers for immu...Read more

Guerbet and IBM Watson Health leverage AI for medical imaging

World |  News | 0 Comment | 25 Sep, 2019

France based Guerbet, a global specialist in contrast agents and solutions for diagnostic and interventional medical imaging, announced that it has signed a new agreement with IBM Watson He...Read more

Enesi Pharma secures innovate UK funding to manufacture ImplaVax

World |  News | 0 Comment | 24 Sep, 2019

Enesi Pharma ("Enesi"), the innovative pharmaceutical company developing unique injectable solid dose drug-device vaccine products, is delighted to announce that it has secured substantial ...Read more

Countries must invest at least 1% more of GDP on primary health care: WHO

World |  News | 0 Comment | 24 Sep, 2019

Countries must increase spending on primary healthcare by at least 1% of their gross domestic product (GDP) if the world is to close glaring coverage gaps and meet health targets agreed in ...Read more

OPTIMA innovations to provide solutions for aseptic API processing

World |  News | 0 Comment | 24 Sep, 2019

At P-Mec, the experts from Optima Pharma and Optima Life Science will be presenting new technologies and an extensive range of services associated with the processing of active pharmaceutic...Read more

Novo Nordisk set to bring innovative treatment for type 2 diabetes

World |  News | 0 Comment | 23 Sep, 2019

Novo Nordisk announced that the U.S. Food and Drug Administration (FDA) has approved Rybelsus® (semaglutide) tablets 7 mg or 14 mg for adults with type 2 diabetes that along with d...Read more

WCG KMR group invites Biopharma companies to enroll in Clinical Trial Cost Study

World |  News | 0 Comment | 20 Sep, 2019

The WIRB-Copernicus Group®’s (WCG™) Clinical Services Division announced on 17 Sep 2019 that the enrolment in WCG KMR Group’s 2019 Clinical Trial Cost Study is now ope...Read more